SCHEMBL19744265

SCHEMBL19744265

COC(=O)c1cc(=O)c2cc(O)cc(F)c2o1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.47
MAPT P10636 2/20 0.42
GPR35 Q9HC97 7/20 0.41
LMNA P02545 1/20 0.41
AKR1B1 P15121 2/20 0.40
TP53 P04637 2/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA7 P43166 1/20 0.38
CA9 Q16790 1/20 0.38
CA14 Q9ULX7 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
HSD17B10 Q99714 1/20 0.38
KMT2A Q03164 1/20 0.37
MAOB P27338 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19744237 0.84 KDM4E (0.56) KDM4EMAPTGPR35LMNATP53
SCHEMBL21175005 0.82 GPR35 (0.50) KDM4EGPR35AKR1B1ALDH1A1
SCHEMBL19744171 0.80 GPR35 (0.48) KDM4EMAPTGPR35LMNAAKR1B1
SCHEMBL19744138 0.79 KDM4E (0.52) KDM4EMAPTGPR35LMNAAKR1B1
SCHEMBL19744145 0.76 GPR35 (0.50) KDM4EMAPTGPR35LMNATP53
SCHEMBL19744176 0.75 KDM4E (0.54) KDM4EMAPTGPR35LMNAAKR1B1
SCHEMBL19744065 0.74 GPR35 (0.47) KDM4EMAPTGPR35LMNATP53
SCHEMBL29540395 0.72 GPR35 (0.60) KDM4EGPR35AKR1B1TP53KMT2A
SCHEMBL19744146 0.72 GPR35 (0.60) KDM4EGPR35AKR1B1TP53KMT2A
SCHEMBL19743740 0.71 GPR35 (0.63) KDM4EGPR35ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109641864-B Anti-infective agents 邓迪大学 2023-04-04 CN disclosed
US-11485720-B2 Anti-infective agents UNIVERSITY OF DUNDEE (GB) 2022-11-01 US disclosed
EP-3472141-B1 ANTI-INFECTIVE AGENTS UNIV DUNDEE (GB) 2022-10-05 EP disclosed
US-20210101877-A1 ANTI-INFECTIVE AGENTS UNIVERSITY OF DUNDEE (GB) 2021-04-08 US disclosed
US-20210101877-A1 ANTI-INFECTIVE AGENTS UNIVERSITY OF DUNDEE (GB) 2021-04-08 US disclosed
US-20190225592-A1 ANTI-INFECTIVE AGENTS UNIVERSITY OF DUNDEE (GB) 2019-07-25 US disclosed
US-20190225592-A1 ANTI-INFECTIVE AGENTS UNIVERSITY OF DUNDEE (GB) 2019-07-25 US disclosed
EP-3472141-A1 ANTI-INFECTIVE AGENTS University Of Dundee (GB) 2019-04-24 EP disclosed
WO-2017221002-A1 ANTI-INFECTIVE AGENTS UNIVERSITY OF DUNDEE (GB) 2017-12-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11485720-B2 Anti-infective agents C1R, RRS1, ARG1 KDM4E 2159/4885MAPT 4773/4885GPR35 3114/4885
US-20210101877-A1 ANTI-INFECTIVE AGENTS C1R, RRS1, ARG1 KDM4E 2159/4885MAPT 4773/4885GPR35 3114/4885
US-20190225592-A1 ANTI-INFECTIVE AGENTS C1R, ARG1, MSR1 KDM4E 2344/4885MAPT 4746/4885GPR35 3007/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.